Search research articles
Contact Us
Filters
Showing results (81-90 of 103) with videos related to
Page
of 11
Sort By:
Multiple Sclerosis and Related Disorders
|
October 15, 2019
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders
Giovanni Novi, Francesca Bovis, Marco Capobianco, et al.
Frontiers in Immunology
|
December 27, 2021
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients
Maristella Pitzalis, Maria Laura Idda, Valeria Lodde, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 15, 2024
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study
Caterina Lapucci, Jessica Frau, Eleonora Cocco, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
April 14, 2020
Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study
Marcello Moccia, Jessica Frau, Antonio Carotenuto, et al.
Frontiers in Immunology
|
September 5, 2022
Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study
Maria Laura Idda, Maristella Pitzalis, Valeria Lodde, et al.
European Journal of Neurology
|
March 29, 2024
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop)
Irene Schiavetti, Alessio Signori, Angela Albanese, et al.
Multiple Sclerosis and Related Disorders
|
February 20, 2026
Abuse in individuals with multiple sclerosis: the SocialMS Italian study
Marta Ponzano, Alessio Signori, Irene Schiavetti, et al.
CNS Drugs
|
May 29, 2025
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study
Giovanni Novi, Francesca Bovis, Chiara Sciolla, et al.
Multiple Sclerosis and Related Disorders
|
May 8, 2024
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab
Elisabetta Signoriello, Alessio Signori, Giacomo Lus, et al.
European Journal of Neurology
|
September 24, 2021
A real-world study of alemtuzumab in a cohort of Italian patients
Cinzia Valeria Russo, Francesco Saccà, Jessica Frau, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 103) with videos related to
Sort By:
Page
of 11
Multiple Sclerosis and Related Disorders
|
October 15, 2019
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders
Giovanni Novi, Francesca Bovis, Marco Capobianco, et al.
Frontiers in Immunology
|
December 27, 2021
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients
Maristella Pitzalis, Maria Laura Idda, Valeria Lodde, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 15, 2024
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study
Caterina Lapucci, Jessica Frau, Eleonora Cocco, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
April 14, 2020
Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study
Marcello Moccia, Jessica Frau, Antonio Carotenuto, et al.
Frontiers in Immunology
|
September 5, 2022
Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study
Maria Laura Idda, Maristella Pitzalis, Valeria Lodde, et al.
European Journal of Neurology
|
March 29, 2024
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop)
Irene Schiavetti, Alessio Signori, Angela Albanese, et al.
Multiple Sclerosis and Related Disorders
|
February 20, 2026
Abuse in individuals with multiple sclerosis: the SocialMS Italian study
Marta Ponzano, Alessio Signori, Irene Schiavetti, et al.
CNS Drugs
|
May 29, 2025
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study
Giovanni Novi, Francesca Bovis, Chiara Sciolla, et al.
Multiple Sclerosis and Related Disorders
|
May 8, 2024
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab
Elisabetta Signoriello, Alessio Signori, Giacomo Lus, et al.
European Journal of Neurology
|
September 24, 2021
A real-world study of alemtuzumab in a cohort of Italian patients
Cinzia Valeria Russo, Francesco Saccà, Jessica Frau, et al.
Page
of 11